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Abstract
We present one case with symptom of paroxysmal abdominal pain for over 20 days. Abdominal computerized
tomography (CT) scan revealed intestinal obstruction and a mass of 6.0 cm × 6.0 cm in size located at the left
adrenal. Chest CT scan showed a lobulated mass of 2.7 cm × 2.7 cm in size at the upper left lung. Core needle
biopsy of the lung mass confirmed the diagnosis of large cell carcinoma. The patient underwent an emergency
abdominal laparotomy and received a chemotherapy regimen that consisted of pemetrexed and cisplatin
postoperatively. In addition, we made a review of the literature of the occurrence, diagnosis and outcome of this
manifestation.
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Background
Primary lung cancer is one of the leading causes of death
in China. Gastrointestinal (GI) metastasis as the initial pre-
sentation of primary lung cancer is relatively rare in the
clinic. Acute GI symptoms such as obstruction, perfora-
tion or bleeding could be the results of small bowel invol-
vement. We report one case of metastatic large cell
carcinoma of the lung with the primary presentation of
acute small bowel obstruction. The current management
plan, as well as prognosis of this patient is discussed. GI
metastasis of lung cancer occurs late in the course of the
disease and is associated with serious clinical complica-
tions and outcomes. Also, we made a review of the litera-
ture relevant to the occurrence, diagnosis and outcome of
GI metastases of lung cancer.
Case presentation
A 58-year-old male patient with a history of meningioma
surgery was admitted to the Emergency Department with
a chief complaint of episodes of paroxysmal abdominal
pain. The pain started 20 days previously that was
aggravated for the last 2 days. Slight tenderness over the
left epigastric region and active bowel sounds were
observed during physical examination. Plain abdominal
X-ray showed dilatation of small bowel with multiple gas-
fluid levels. The abdominal computerized tomography
(CT) (Figure 1) scan revealed intestinal obstruction and a
mass of 6.0 cm × 6.0 cm in size which showed enhance-
ment in contrast-enhanced CT near the left adrenal gland.
The chest CT (Figure 2) scan showed a 2.7 cm × 2.7 cm
lobulated mass at the upper left lung with localized pneu-
monia changes. Brain MRI suggested no evidence of cere-
bral or cerebellar metastasis. A CT-guided core needle
biopsy of the lung mass confirmed the diagnosis of large
cell carcinoma of the lung(Figure 3).
Due to the life-threatening nature of complete obstruc-
tion, the patient underwent an emergency abdominal
laparotomy. Exploration of the abdominal cavity revealed
a mass of 12.0 cm × 10.0 cm in size in the jejunum which
had already invaded the bladder. The abdominal compu-
terized tomography scan revealed metastatic tumor mass
of jejunum (Figure 4). The mass, the invaded jejunum and
part of the bladder was resected. Another hard and fixed
mass of 6.0 cm × 6.0 cm in size near the left adrenal gland
was also identified and it was not removed during the pro-
cedure due to its invasion to the surrounding of great
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vessels. Post-operative pathological analysis of the surgical
specimen showed the presence of poorly differentiated
carcinoma with rhabdoid differentiation (Figure 5). Immu-
nohistochemical (IHC) staining revealed that the tumor
cells were positive for CK7, vimentin, and partially positive
for CA153 receptors. Combining with the results of the
lung biopsy, we concluded that the jejunal mass was a
metastasis from the primary large cell carcinoma of lung.
Postoperatively, the patient complained severe contin-
uous upper left abdominal pain which intensified
progressively. Additional CT scan revealed that the mass
near the left adrenal gland had swollen to 8.8 cm × 8.3
cm in size, while the upper left lung mass had increased
to 4.5 cm × 4.0 cm in size, and localized pneumonia,
atelectasis and pleural effusion of left thoracic cavity had
also developed. The patient was diagnosed with stage IV
large cell lung cancer with jejunum and left adrenal
gland metastasis. The chemotherapy regimen consisted
of pemetrexed 500 mg/m2 at day 1 and cisplatin 25 mg/
m2 on day 1 to day 3. However, the abdominal pain was
not relieved with this treatment. Two weeks after the
first cycle of chemotherapy, the patient suddenly pre-
sented with abnormal activities of the right limbs, with a
positive result in the finger-to-nose test. New brain MRI
scan revealed multiple metastatic lesions with prominent
surrounding edema in various cerebral and cerebellar
regions. The patient suffered an epileptic seizure and
died three days later.
Discussion
The most frequently involved metastatic organs of lung
cancer are bones, liver, brain and adrenals, while metas-
tases to the gastrointestinal system is relatively rare with
a frequency ranging from 0.2% to 1.7% in several studies
[1-3]. However, autopsy data have suggested a much
higher frequency of GI metastases of lung cancer than
clinically reported cases and there is a prevalence of
4.7% to 14% [4,5]. Small bowel is the most commonly
reported GI metastatic site of lung cancer [5,6]. Clini-
cally significant metastases to the small bowel are rare
and occur only in the advanced stage of lung cancer.
Most patients with small bowel metastases have no spe-
cific symptoms such as anorexia, abdominal pain, dis-
tention and diarrhea. With the progression of disease,
Figure 1 The abdominal computerized tomography scan revealed intestinal obstruction (a) and a mass measuring of 6.0 cm × 6.0 cm
in size which showed enhancement in intensified tomography near the left adrenal gland (b).
Figure 2 The chest computerized tomography scan showed a
2.7 cm × 2.7 cm lobulated mass at the upper left lung with
localized pneumonia changes.
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life threatening symptoms do present, such as small
bowel obstruction, perforation or even bleeding[7-10].
Hillenbrand reviewed the literature from 1967 to 2003
and found 58 documented cases with metastasis to the
small bowel of primary lung cancer. Over 80% of the
cases with small bowel metastases were male, with ages
ranging from 36 to 78 years old and metastases pre-
sented as perforation (59%), obstruction (29%) and
hemorrhage (10%) [11]. In addition, McNeill et al. [6]
reported that small bowel metastases were always asso-
ciated with other metastatic sites (with an average of 4.8
sites), thus suggesting a late stage of the lung cancer.
These patients often had a poor prognosis with a life-
expectancy less than 16 weeks.
Yang et al. [1] reported in their study that squamous
cell carcinoma is the most common cell type of lung can-
cer which develop GI metastases [2,4,12]. But other stu-
dies showed that poorly differentiated adenocarcinoma
and large cell carcinoma of the lung have higher inci-
dence of GI metastases. McNeill et al. [6] reported that
12 of 31 (39.0%) patients with large cell carcinoma had
small bowel metastases. Yoshimoto et al. [4] evaluated
470 cases of GI metastases from primary lung cancer
over 33 years and their data showed that 30% of cases
were large cell carcinoma. Patients with large cell carci-
noma had a significantly higher rate of GI metastases
(P = 0.004, odds ratio 3.524) compared with patients with
non-large cell carcinoma. Because of the difficulty in
early detection of GI diseases, the diagnosis of small
bowel metastases was often delayed before it presented
with life-threatening complications, which frequently
required emergency surgeries [1,13]. Kim evaluated the
CT scan findings in 28 patients with gastrointestinal
metastasis from lung cancer and found 5/26 patients had
two lesions and 21 patients had only one lesion. The
shape of GI lesion varied on CT scans, presenting as wall
thickening in 14 cases, an intraluminal polypoid mass in
14 cases, and an exophytic mass in the other three cases
[14]. PET is more accurate than CT or other conven-
tional imaging methods for the diagnosis of metastatic
malignant sites. However, the role of PET in the diagno-
sis of lung cancer GI metastasis is still controversial
because of the lack of enough clinical cases. Small bowel
metastases from primary lung cancer were usually
Figure 3 Microscopic images of lung biopsy (a) hematoxylin-eosin staining × 100, showing large, undifferentiated tumor cells with
rhabdoid variant; (b) immunoperoxidase × 400 showing CK7 immunoreactivity of cancer cells.
Figure 4 The abdominal computerized tomography scan revealed metastatic tumor mass of jejunum (a and b).
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confirmed by pathological analysis, with the help of
immunohistochemical staining of TTF-1, CDX2, CK7
and CK20, to differentiate the primary small bowel
tumor from metastases of lung cancer [2].
So far, surgical resection is the mainstay treatment for
small bowel metastases from large cell carcinoma of the
lung. Individualized treatment may also be helpful.
Advances in chemotherapy and supportive care may lead
to the improvement of the survival rate for these lung
cancer patients. According to the report from a phase III
study (JMDB trial), overall survival was statistically higher
in patients with large cell carcinoma histology who
received treatment of cisplatin plus pemetrexed versus
cisplatin plus gemcitabine, the latter being the standard
first-line regimen of non-small cell lung cancer; n = 153;
10.4 months v 6.7 months, respectively [15].
In our case, small bowel obstruction was the initial
clinical symptom for this male patient. Primary lung
large cell carcinoma was confirmed by a pathologist and
at the same time small bowel and left adrenal metastases
were suggested by CT scan (stage IV). Unfortunately the
patient did not benefit from an emergency operation and
chemotherapy. Multiple brain metastases soon developed
and the patient died 64 days after the diagnosis. The his-
tological type of large cell carcinoma of the lung, metas-
tases in multiple sites, heavy tumor load and surgical
stroke might be the reasons of the poor prognosis. Dur-
ing the clinical course, physicians should be aware of gas-
trointestinal tract metastases if the patient with lung
cancer presents with gastrointestinal tract symptoms.
Progression of examinations for screening small bowel
diseases will be helpful for doctors to diagnose more
cases of small bowel metastases from lung cancer in the
future. Earlier resection of the gastrointestinal metastases
to alleviate the symptoms and decrease tumor load may
be beneficial to the patients and achieve a better prog-
nosis [11,16-18].
Conclusion
In conclusion, small bowel metastases from lung cancer
are not uncommon and occur only in the advanced
stage of lung cancer, particularly if patients have the his-
tological type of large cell lung carcinoma. Physicians
should keep in mind that the incidence of small bowel
metastases as a site of lung cancer spread is increasing
as patients with lung cancer now live longer due to
improved treatment.
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